Showing results (1591-1600 of 1,679) with videos related to

Sort By:
Pageof 168
Pediatrics|June 5, 2001
Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settingsW E Pelham, E M Gnagy, L Burrows-Maclean, et al.
Analytical and Bioanalytical Chemistry|April 22, 2008
Certification of standard reference materials containing bitter orangeL C Sander, K Putzbach, B C Nelson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 6, 2023
Rethinking Immunological Risk: A Retrospective Cohort Study of Severe SARS-Cov-2 Infections in Individuals With Congenital ImmunodeficienciesAlan A Nguyen, Saddiq B Habiballah, Brenna LaBere, et al.
Plos One|July 5, 2013
Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemiaMatthew J Cooper, Nathan J Cox, Eric I Zimmerman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 12, 2026
Rapid Drug Desensitization in Pediatric Patients: A Multicenter StudySummer Tk Sze, Daniel Leung, Alan A Nguyen, et al.
European Review for Medical and Pharmacological Sciences|May 4, 2023
Soft tissue regeneration in animal models using grafts from adipose mesenchymal stem cells and peripheral blood fibrin gelT D Huynh, H K Nguyen, A M Inchingolo, et al.
The Lancet. Child & Adolescent Health|January 12, 2023
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trialsEric A F Simões, Shabir A Madhi, William J Muller, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Rethinking immunologic risk: a retrospective cohort study of severe SARS-CoV-2 infections in individuals with congenital immunodeficienciesAlan A Nguyen, Saddiq B Habiballah, Brenna LaBere, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026
CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitinationRuhi Polara, Briony L Gliddon, Raja Ganesan, et al.
Research Square|November 24, 2025
Sequential Lymphotoxin Beta Receptor and Retinoic Acid Receptor signals regulate cDC2 fatesAlbert A Nguyen, Logan Fisher, Jennifer S Y Ahn, et al.
Pageof 168